Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record is now available, describing a phase 2 study of pembrolizumab combined with SBRT for metastatic renal cell cancer. It includes the study design and eligibility details, and reports that the study is completed with an actual enrollment of four participants.
    Difference
    47%
    Check dated 2026-11-08T13:58:18.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page remains an error page.
    Difference
    0.2%
    Check dated 2026-11-01T15:26:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T14:13:10.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:51:14.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:42:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page is now shown as a 403 Forbidden error, replacing the usual study details and navigation with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-20T19:44:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.